TGFB1 and chronic obstructive pulmonary disease: Studies have shown that treating airway smooth muscle cells in a lipopolysaccharide-induced COPD rat model with extracellular matrix components upregulates expression of cytokine factors like TGF-β1 and IL-6, but downregulates matrix metalloproteinase 9 (MMP-9) (98).